Coherus Content With Dual Pipeline Strategy

US Firm Reveals Full-Year Udenyca Biosimilar Sales

 
• By Dean Rudge
Road_Mountain
Coherus is finally in year-end profit after launching its first product • Source: Shutterstock

More from Strategy

More from Business